Nasdaq Halts Charming Medical Limited
Globenewswire·2025-11-26 12:00

Core Points - Trading in Charming Medical Limited (Nasdaq: MCTA) has been halted by Nasdaq for additional information requested from the company [1] - The Securities and Exchange Commission (SEC) previously suspended trading in MCTA from November 12, 2025, to November 25, 2025 [1] - The last sale price of MCTA's ordinary shares was $29.355 [1] Summary by Sections - Trading Suspension - Nasdaq has halted trading in Charming Medical Limited for further information [1] - SEC's trading suspension lasted from 04:00 on November 12, 2025, to 23:59 on November 25, 2025 [1] - Company Information - Trading will remain halted until the company fully satisfies Nasdaq's request for additional information [2] - For further news and information, stakeholders are advised to contact the company directly or check under the company's symbol on the Nasdaq website [2]